Heterogeneity in β cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome

Human Reproduction

Volumn 12, Issue 9, 1997, Pages 1897-1901

  Ciampelli, M ^a   Fulghesu, A M ^a   Cucinelli, F ^a   Pavone, V ^a   Caruso, A ^a   Mancuso, S ^a   Lanzone, A ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Hepatic clearance; Insulin; Insulin resistance; Obesity; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; C PEPTIDE; ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADOLESCENT; ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE UTILIZATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN METABOLISM; INSULIN RELEASE; INSULIN SENSITIVITY; LIVER CLEARANCE; LIVER METABOLISM; LUTEINIZING HORMONE BLOOD LEVEL; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; TESTOSTERONE BLOOD LEVEL;

EID: 0030783746     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/12.9.1897     Document Type: Article

References (29)

1. Anttila, L., Rouru, J., Penttila, T. et al. (1996) Normal serum uric acid concentrations in women with polycystic ovary syndrome. Hum. Reprod., 11, 2405-2407.
2. Barbieri, R.L. and Ryan, K.J. (1983) Hyperandrogenism, insulin resistance and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiology features. Am. J. Obstet. Gynecol., 147, 90-101.
3. Bergman, R.N., Finegood, D.T. and Ader, M. (1985) Assessment of insulin sensitivity in vivo. Endocr. Rev., 6, 45-75.
4. Bonora, E., Zavaroni, I., Bruschi, F. et al. (1984) Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or mpaired insulin metabolism? J. Clin. Endocrinol. Metab., 59, 1121-1127.
5. Buffington, C.K. and Kitabchi, A.E. (1994) Evidence for a defect in insulin metabolism in hyperandrogenic women with polycystic ovarian syndrome. Metabolism, 11, 1367-1372,
6. Burghen, G.A., Givens, J.R. and Kitabchi, A.E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin, Endocrinol. Metab., 50, 113-116.
7. Campbell, P.J. and Gerivh, J.E. (1990) Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. J. Clin. Endocrinol. Metab., 70, 1114-1118.
8. Chang, R.J., Nakamura, R.M., Judd, H.L. et al. (1983) Insulin resistance in non-obese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 57, 356-361.
9. De Fronzo, R.A., Tobin, J.D. and Andres, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol., 237, E214-E223.
10. Despres, J.P., Nadeau, A., Tremblay, A. et al. (1989) Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes, 38, 304-309.
11. Dunaif, A. and Finegood, D.T. (1996) β-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 81, 942-947.
12. Dunaif, A., Graf, M., Mandeli, J. et al. (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and/or hyperinsulinemia. J. Clin. Endocrinol. Metab., 65, 499-507.
13. Dunaif, A., Mandeli, J., Fluhr, H. et al. (1988) The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal secretion in patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 66, 131-139.
14. Dunaif, A., Segal, K.R., Futterweit, W. et al. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-1174.
15. Ehrman, D.A., Sturis, J., Byrne, M.M. et al. (1995) Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J. Clin. Invest., 96, 520-527.
16. Faber, O.K., Christensen, K., Kehletm, H. et al. (1981) Decreased insulin removal contributes to hyperinsulinemia in obesity. J. Clin. Endocrinol. Metab., 53, 618-621.
17. Fulghesu, A.M., Ciampelli, M., Fortini, A. et al. (1995) Effect of opioid blockade on insulin metabolism in polycystic ovarian disease. Hum. Reprod., 10, 2253-2257.
18. Golland, I.M., Vaughan, W.C., Shalet, S.M. et al. (1989) Lack of predictive value of HbAl for impaired glucose tolerance in polycystic ovary syndrome. Gynecol. Endocrinol., 3, 229-235.
19. Holte, J., Bergh, T., Berne, C. et al. (1994) Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J. Clin. Endocrinol. Metab., 78, 1052-1058.
20. Holte, J., Bergh, T., Berne, C. et al. (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 80, 2586-2593.
21. Lanzone, A., Fulghesu, A.M., Andreani, C.L. et al. (1990) Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist. Hum. Reprod., 5, 143-149.
22. Lanzone, A., Fulghesu, A.M., Cucinelli, F. et al. (1995) Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion. J. Clin. Endocrinol. Metab., 80, 3501-3506.
23. Morales, A.J., Laughlin, G.A., Butzow, T. et al. (1996) Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J. Clin. Endocrinol. Metab., 81, 2854-2864.
24. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28, 1039-1057.
25. O'Meara, N.M., Blackman, J.D., Ehrman, D.A. et al. (1993) Defects in β-cell function in functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab., 76, 1241-1247.
26. Ovesen, P., Moller, J., Ingerslev, H.J. et al. (1993) Normal basal and stimulated fuel metabolism in lean women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 77, 1636-1640.
27. Polonsky, K.S. and Rubenstein, A.H. (1984) C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes, 28, 1039-1057.
28. Prelevic, G.M., Wurzburger, M.I., Balint, P.L. et al. (1992) Twenty-four h serum growth hormone, insulin, c-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Horm. Res., 37, 125-131.
29. Stuart, C.A., Peters, E.J., Prince, M.J. et al (1986) Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess. Metabolism, 35, 197-205.